Immunophenotypic profile of adult acute myeloid leukemia (AML): Analysis of 267 cases in Thailand

Asian Pacific Journal of Allergy and Immunology

Volumn 21, Issue 3, 2003, Pages 153-160

  Auewarakul, Chirayu Udomsakdi ^a   Promsuwicha, Orathai ^a   U pratya, Yaowaluk ^a   Pattanapanyasat, Kovit ^a   Issaragrisil, Surapol ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CD19 ANTIGEN; CD2 ANTIGEN; CD34 ANTIGEN; CD38 ANTIGEN; CD56 ANTIGEN; CD7 ANTIGEN; HLA DR ANTIGEN; MEMBRANE ANTIGEN;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EPIDEMIOLOGICAL DATA; ETHNOLOGY; FEMALE; FLOW CYTOMETRY; FREQUENCY ANALYSIS; GEOGRAPHIC DISTRIBUTION; HUMAN; IMMUNOPHENOTYPING; JAPAN; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PATHOGENESIS; PROMYELOCYTIC LEUKEMIA; SOUTHEAST ASIA; THAILAND; WESTERN HEMISPHERE;

ACUTE DISEASE; ADULT; ANTIGENS, CD; ANTIGENS, SURFACE; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; FEMALE; FLOW CYTOMETRY; GLYCOPHORIN; GRANULOCYTE PRECURSOR CELLS; GRANULOCYTES; HEMOGLOBINS; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, MYELOID; LEUKOCYTE COUNT; MALE; MIDDLE AGED; PLATELET COUNT; STATISTICS; THAILAND;

EID: 1542315643     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Greenberg PL, Gordeuk V, Issaragrisil S, Siritanaratkul N, Fucharoen S, Ribeiro RC. Major hematologic diseases in the developing world- new aspects of diagnosis and management of thalassemia, malarial anemia, and acute leukemia. Hematology (Am Soc Hematol Educ Program) 2001; 479-98.
2. Issaragrisil S. Epidemiology of aplastic anemia in Thailand. Thai Aplastic Anemia Study Group. Int J Hematol 1999; 70: 137-40.
3. Pramoonjago P, Pakdeesuwan K, Siripanyaphinyo U, Chinprasertsuk S, Kinoshita T, Wanachiwanawin W. Genotypic, immunophenotypic and clinical features of Thai patients with paroxysmal nocturnal haemoglobinuria. Br J Haematol 1999; 105: 497-504.
4. Sukpanichnant S, Sonakul D, Piankijagum A, et al. Malignant lymphoma in Thailand: changes in the frequency of malignant lymphoma determined from a histopathologic and immunophenotypic analysis of 425 cases at Siriraj Hospital. Cancer 1998; 83: 1197-204.
5. Intragumtornchai T, Wannagrairot P, Chaimongkol B, et al. Non-Hodgkin's lymphoma in Thailand. A retrospective pathologic and clinical analysis of 1391 cases. Cancer 1996; 78: 1813-9.
6. Lowenberg B, Downing JR, Burnett A. Acute myeloid leukemia, N Engl J Med 1999; 341: 1051-62.
7. Nakase N, Bradstock K, Sartor M et al. Geographic heterogeneity of cellular characteristics of acute myeloid leukemia: a comparative study of Australian and Japanese adult cases. Leukemia 2000; 14: 163-8.
8. Borowitz MJ, Guenther KL, Shults KE, et al. Immunophenotyping of acute leukemia by flow cytometric analysis. Use of CD45 and right-angle light scatter to gate on leukemic blasts in three-color analysis. Am J Clin Pathol 1993; 100: 534-40.
9. Bene MC, Castoldi G, Knapp W, et al; for the European Group for the Immunological Characterization of Leukemias (EGIL). Proposal for the immunological classification of acute leukemias. Leukemia 1995; 9: 1783-6.
10. Jenning CD, Foon KA. Recent advances in flow cytometry: application to the diagnosis of hematologic malignancy. Blood 1997; 90: 2863-92.
11. Traweek ST. Immunophenotypic analysis of acute leukemia. Am J Clin Pathol 1993; 99: 504-12.
12. Bradstock K, Matthews J, Benson E, et al. and the Australian Leukaemia Study Group. Prognostic value of immunophenotyping in acute myeloid leukemia. Blood 1994; 84: 1220-5.
13. De Nully Brown P, Jurlander J, Pedersen-Bjergaard J, Victor MA, Geisler CH. The prognostic significance of chromosomal analysis and immunophenotyping in 117 patients with de novo acute myeloid leukemia. Leuk Res 1997; 21: 985-95.
14. Legrand O, Perrot J-Y, Baudard M, et al. The immunophenotyping of 177 adults with acute myeloid leukemia: proposal of a prognostic score. Blood 2000; 96: 870-7.
15. Stelzer GT, Marti G, Hurley A, et al. US-Canadian consensus recommendations on the immunophenotypic analysis of hematologic neoplasia by flow cytometry: standardization and validation of laboratory procedures. Cytometry 1997; 30: 214-30.
16. 3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmocokinetics in relapsed patients. Blood 1997; 89: 3354-60.
17. Tallman MS, Andersen JW, Schiffer CA, et al. All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol. Blood 2002; 100: 4298-302.
18. Roberts GT, Spence DG, Padmos MA, Sheth KV, Clink H, Ernst P. Morphologic immunophenotypic and cytogenetic patterns of adult acute myeloid leukemia in Saudi Arabia. Leuk Res 1992; 16:181-90.
19. Painetta E, Van Ness B, Bennett J. Lymphoid lineage associated features in acute myeloid leukemia: phenotypic and genotypic correlations. Br J Haematol 1992; 82: 324-31.
20. Tisone JA, Bohman JE, Theil KS, Brandt JT. Aberrant expression of CD19 as a marker of monocytic lineage in acute myelogenous leukemia. Am J Clin Path 1997; 107: 283-91.
21. Kita K, Nakase K, Miwa H, et al. Phenotypical characteristics of acute myelocytic leukemia associated with the t(8;21)(q22;22) chromosomal abnormality: frequent expression of immature B-cell antigen CD19 together with stem cell antigen CD34. Blood 1992; 89: 470-7.
22. Hsiao CH, Tang JL, Yao M, et al. High incidence of CD56 expression and relapse rate in acute myeloid leukemia patients with t(8;21) in Taiwan. J Formos Med Assoc 2002; 101: 393-8.
23. Grimwade D, Outram SV, Flora R, Ings SJ, Pizzey AR, Morilla R, Craddock CF, Linch DC, Solomon E. The T-lineage-affiliated CD2 gene lies within an open chromatin environment in acute promyelocytic leukemia cells. Cancer Res 2002; 62: 4730-5.
24. Maynadie M, Gerland L, Aho S, et al. Clinical value of the quantitative expression of the three epitopes of CD34 in 300 cases of acute myeloid leukemia. Haematologica 2002; 87: 795-803.
25. Krause DS, Fackler MJ, Civin CI, et al. CD34. Structure, biology, and clinical utility. Blood 1996; 87: 1-13.
26. Solary E, Casasnovas RO, Campos L, et al. Surface markers in adult acute myeloblastic leukemia: correlation of CD19+, CD34+ and CD14+/DR phenotypes with shorter survival. Groupe d'Etude Immunologique des Leucemies (GEIL). Leukemia 1992; 6: 393-9.
27. Hrusak O, Porwit-MacDonald A. Antigen expression patterns reflecting genotype of acute leukemias. Leukemia 2002; 16: 1233-58.
28. Grimwade D, Walker H, Oliver F, et al. The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trials. The Medical Research Council Adult and Children's Leukaemia Working Parties. Blood 1998; 92: 2322-33.
29. Slovak ML, Kopecky KJ, Cassileth PA, et al. Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/ Eastern Cooperative Oncology Group study. Blood 2000; 96: 4075-83.
30. Jaffe ES, Harris NL, Stein H, Vardiman JW. (eds.). Pathology and genetics of tumours of haematopoietic and lymphoid tissues. World Health Organization classification of tumours. 3rd edition. Lyon, France: International Agency for Research on Cancer; 2001.
31. Bene MC, Bernier M, Castoldi G, et al. Impact of immunophenotyping on management of acute leukemias. Haematologica 1999; 84: 1024-34.
32. Venditti A, Buccisano F, Del Poeta G, et al. Level of minimal residual disease after consolidation therapy predicts outcome in acute myeloid leukemia. Blood 2000; 96: 3948-52.